Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 14
Review
New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,634 | Dovepress* | 11,076+ | 1,789 | 12,865 | |
| PubMed Central* | 2,558 | 860 | 3,418 | ||
| Totals | 13,634 | 2,649 | 16,283 | ||
| *Since 23 April 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 1 | 0 | 0 | 1 | 2 |
View citations on PubMed and Google Scholar